Biotech Alliances International to Represent Sirbal in Sale of Lead Assets

SAN FRANCISCO–(BUSINESS WIRE)–Biotech Alliances International, a San Francisco-based life sciences investment bank, announced today that it is representing Sirbal Ltd. a pharmaceutical company specializing in developing non-toxic herbal treatments based on traditional Chinese medicine. Sirbal is offering for sale its lead asset, SIRB-001, a botanical extract to topically treat dermatological indications. It is estimated that more than three percent of the worldwide population suffers from not
Source: BusinessWire-Primary

Biotech Alliances International to Represent Sirbal in Sale of Lead Assets